BRIEF published on 03/25/2026 at 09:05, 15 days 11 hours ago Nynomic AG's Path to Recovery and Growth in 2026 Profitable Growth Nynomic AG FY25 Financials LayTec Semiconductor Tools
PRESS RELEASE published on 03/25/2026 at 09:00, 15 days 11 hours ago Original-Research: Nynomic AG (von NuWays AG): BUY Nynomic AG FY25 prelims show signs of recovery with group revenues at €92.6m. FY26 guidance expects sales growth and higher profit margins. LayTec niche in InP semiconductor crucial for future growth Sales Growth Profitable Growth Nynomic AG FY26 Guidance LayTec FY25 Prelims InP Semiconductor
BRIEF published on 11/07/2025 at 09:06, 5 months 2 days ago Nynomic AG Shows Signs of Recovery Amid Challenging Conditions Financial Guidance Order Intake Q3 Results Nynomic AG Efficiency Program
PRESS RELEASE published on 11/07/2025 at 09:01, 5 months 2 days ago Original-Research: Nynomic AG (von NuWays AG): Buy Nynomic AG's Q3 preliminary results show signs of recovery, with improved order intake and positive EBIT. Sales guidance lowered for FY25, but positive outlook with efficiency program EBIT Order Intake Q3 Results Nynomic AG Efficiency Program
BRIEF published on 08/14/2025 at 09:05, 7 months 26 days ago Nynomic AG Faces Challenges Amid Restructuring and Weak Demand Restructuring Mid-term Prospects Revenue Decline Nynomic AG NyFIT2025
PRESS RELEASE published on 08/14/2025 at 09:00, 7 months 26 days ago Original-Research: Nynomic AG (von NuWays AG): BUY Nynomic AG research update: Q2 revenue down 13%, weak demand. Forecast adjustment, efficiency program NyFIT2025, and lowered price target. BUY recommendation maintained Research Update Price Target Nynomic AG Efficiency Program Q2 Revenue
BRIEF published on 05/09/2025 at 09:06, 11 months ago Nynomic AG: A Challenging Start to 2025 Amid Market Uncertainty Order Backlog Financial Outlook Nynomic AG Semiconductor Market Market Uncertainty
PRESS RELEASE published on 05/09/2025 at 09:01, 11 months ago Original-Research: Nynomic AG (von NuWays AG): BUY Nynomic AG (DE000A0MSN11) research update: Preliminary Q1 results show sales decline, but management expects gradual improvements throughout FY25. Reaffirmed mid-term targets and BUY rating BUY Rating Research Update Sales Decline Nynomic AG Mid-term Targets
BRIEF published on 03/13/2025 at 09:06, 1 year ago NuWays AG Affirms Buy Rating for Nynomic AG Amid Challenges NuWays AG M&A Strategy Q4 Sales Nynomic AG Growth Guidance
PRESS RELEASE published on 03/13/2025 at 09:01, 1 year ago Original-Research: Nynomic AG (von NuWays AG): Buy Nynomic AG released preliminary Q4 figures, expecting a return to growth in FY25 despite macroeconomic challenges. Management aims for mid-term sales of at least €200m Nynomic AG Macroeconomic Challenges FY25 Guidance Preliminary Q4 Figures Mid-term Sales Targets
Published on 04/09/2026 at 19:15, 1 hour 11 minutes ago Murchison Minerals Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Published on 04/09/2026 at 16:00, 4 hours 26 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 5 hours 46 minutes ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 6 hours 26 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 6 hours 56 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 18:15, 2 hours 11 minutes ago REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 15:40, 4 hours 46 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 18:35, 1 hour 51 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 15:57, 4 hours 28 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 13 hours 26 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 1 day 2 hours ago Publication of the 2025 Universal Registration Document
